February 27, 2019

Eisai, Empatica to Co-Promote Embrace2 Device for Epilepsy in US

Eisai and Empatica have entered into an agreement in the US to co-promote the Embrace2 smartband device, the first FDA-cleared, wrist-worn wearable within the field of epilepsy for detecting patterns that may be associated with convulsive seizures available for use as a medical device for adults and children.

“We are very proud to be a part of this collaboration with Eisai to promote Embrace2, which provides families living with epilepsy an option to help monitor convulsive seizures at home or in a healthcare setting – even at night,” said Matteo Lai, Co-Founder and CEO of Empatica. “Our product was designed with our patients’ lifestyles and needs in mind to help improve the likelihood that a trusted caregiver will be there during the critical moments after a seizure happens.

Related News